The Sunscreen Debate — Is More Really More
Even though the FDA proposed a cap on SPFs at 50+, brands are still putting sky-high skin protection on the shelves and consumers may be buying in. From 75 to 85 and now to 100, the auctioneer is raising the number and raising it fast - but, is there any merit in SPFs that high, or is just brand hype?
Also on this episode
* Yohini Appa, Senior Director of Scientific Affairs at Johnson & Johnson Consumer Companies, of which Neutrogena is a subsidiary.
* Dr. Barbara A. Gilchrest, (M.D) Department of Dermatology, Boston University School of Medicine
Comments disabled after 14 days





















